Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2012
03/22/2012US20120073022 Sun quest lettuce variety
03/22/2012US20120073018 Jatropha curcas curcin genes, tissue-specific promoters and generation of curcin-deficient transgenic jatropha plants
03/22/2012US20120073016 Axmi-150 delta-endotoxin gene and methods for its use
03/22/2012US20120073014 Zantedeschia Variety 110167-55633
03/22/2012US20120073013 Lettuce variety paulita (ls9498)
03/22/2012US20120073012 Lettuce variety carini (ls9499)
03/22/2012US20120073011 Lettuce cultivar gandhi
03/22/2012US20120073010 Plants and seeds of sorghum variety gsv958220
03/22/2012US20120073007 Pea line 08560906
03/22/2012US20120073006 Plants and seeds of sorghum variety gsv682287
03/22/2012US20120073004 Hybrid Light Chain Mice
03/22/2012US20120073003 Apobec3 mediated dna editing
03/22/2012US20120073001 Methods and compositions for treating or preventing pruritis
03/22/2012US20120071859 Inducible interleukin-12
03/22/2012US20120071631 Isolation and Characterization of Novel Green Fluorescent Proteins from Copepods
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120071540 Compositions and Methods Using siRNA Molecules and siRNA Cocktails for the Treatment of Breast Cancer
03/22/2012US20120071539 Compounds and methods for modulating the silencing of a polynucleotide of interest
03/22/2012US20120071523 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071468 Methods of treating mild cognitive impairment (mci) and related disorders
03/22/2012US20120071434 Substituted nucleotide analogs
03/22/2012US20120071422 Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor
03/22/2012US20120071419 Target-Specific Non-Antibody Protein and Method for Preparing the Same
03/22/2012US20120071418 Inhibitors of Human EZH2 and Methods of Use Thereof
03/22/2012US20120071417 Methods of inhibiting cancer cell growth with hdac inhibitors and methods of screening for hdac10 inhibitors
03/22/2012US20120071406 Modified vegf-a with improved angiogenic properties
03/22/2012US20120071399 Sulfation of wnt pathway proteins
03/22/2012US20120071397 Methods for Hematopoietic Stem Cell Transplantation
03/22/2012US20120071396 Compositions and Methods for Inhibiting the Interaction Between CFTR and CAL
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120071350 Tumor-initiating cells and methods for using same
03/22/2012US20120070898 iCell
03/22/2012US20120070897 Method For Enucleating Nucleated Erythrocyte, And Enucleation Inducer
03/22/2012US20120070896 Method for producing induced pluripotent stem cells and method for culturing the same
03/22/2012US20120070895 Method and apparatus for sustaining viability of biological cells on a substrate
03/22/2012US20120070894 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
03/22/2012US20120070893 Methods for producing nonadherent avian cell lines
03/22/2012US20120070890 Targeted gene modification by parvoviral vectors
03/22/2012US20120070876 Variant form of urate oxidase and use thereof
03/22/2012US20120070868 Production of odd chain fatty acid derivatives in recombinant microbial cells
03/22/2012US20120070863 Novel beta-galactoside-alpha2,3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
03/22/2012US20120070857 ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
03/22/2012US20120070851 Antibody specific to methicillin resistant staphylococcus aureus, detection method and kit for methicillin resistant staphylococcus aureus using the same
03/22/2012US20120070847 Method For Detecting And Purifying Pancreatic Beta Cells
03/22/2012US20120070819 Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors
03/22/2012US20120070511 Mitochondrial inhibitors and uses thereof
03/22/2012US20120070466 Conjugated Polymeric Material and Uses Thereof
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070452 Immunoadjuvant composition and use thereof
03/22/2012US20120070450 Leukemia stem cell markers
03/22/2012US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070439 Antigen-binding proteins
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070436 Antigen-binding proteins
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070433 Flavonoid hydrogel
03/22/2012US20120070430 Identification of tumor-associated markers for diagnosis and therapy
03/22/2012US20120070419 Method of altering the differentiative state of a cell and compositions thereof
03/22/2012US20120070415 Azido nucleosides and nucleotide analogs
03/22/2012US20120070411 Substituted nucleotide analogs
03/22/2012US20120070407 Therapy for Promoting Cell Growth
03/22/2012US20120070389 Methods for identifying treatments that treat and/or prevent uv irradiation inducing photoaging
03/22/2012US20120070383 Polymeric nano-carriers with a linear dual response mechanism and uses thereof
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012DE102009041885B4 Separation von Mesenchymalen Stammzellen Mesenchymal stem cells separation of
03/22/2012DE102007020302B4 Verbesserte dreidimensionale biokompatible Gerüststruktur, die Nanopartikel beinhaltet Improved three-dimensional biocompatible scaffold structure, the nanoparticles includes
03/22/2012CA2811504A1 Composition for maintaining function of platelets
03/22/2012CA2811208A1 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
03/22/2012CA2810390A1 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/21/2012EP2431482A2 Anti-cancer drug screening method using ror
03/21/2012EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms
03/21/2012EP2431473A1 Methods for genetic control of insect infestations in plants and compositions thereof
03/21/2012EP2431460A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
03/21/2012EP2431459A1 Components of cell culture media produced from plant cells
03/21/2012EP2431458A1 Components of cell culture media produced from plant cells
03/21/2012EP2430923A1 Compositions and methods for liver growth and liver protection
03/21/2012EP2430454A1 Imaging and evaluating embryos, oocytes, and stem cells
03/21/2012EP2430155A1 Automated separation of tissue layers
03/21/2012EP2430154A1 Methods for the collection and maturation of oocytes
03/21/2012EP2430153A1 Methods of using immunoglobulin aggregates
03/21/2012EP2430057A1 Temperature-responsive co-polymers and uses thereof
03/21/2012EP2429531A2 Use of lipid conjugates in the treatment of diseases associated with vasculature
03/21/2012EP2429496A1 Composition and method of preparation of polysaccharide gel-based artificial, biodegradable skin scaffolds
03/21/2012EP2329262B1 Filter system for extracorporeal depletion of activated polymorphonuclear leukocytes (pmns)
03/21/2012EP2185710B1 Eukaryotic promoters for gene expression
03/21/2012EP1853629B1 Human ring specific bnp antibodies
03/21/2012EP1809750B1 Selection of host cells expressing protein at high levels
03/21/2012EP1734989B1 Novel use of antisecretory factor
03/21/2012EP1650302B1 Protein capable of deposition onto extracellular matrix
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012CN1867665B Myeloma cell culture in transferrin-free low iron medium
03/21/2012CN1554764B Recombinant mva virus, and the use thereof
03/21/2012CN102388137A Novel lysophospholipid acyltransferase
03/21/2012CN102388136A Novel nuclear reprogramming substance
03/21/2012CN102388135A Protease for wound conditioning and skin care